Aktie PRISMMEDI6 PRISM MEDICO AND PHARMACY LIMITED
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Prism Medico and Pharmacy Limited

Aktien

PRISMMEDI6

INE730E01016

PRISMMEDI6

Verzögert Bombay S.E.
Andere Börsenplätze
 09:50:10 29.05.2024 		% 5 Tage % 1. Jan.
21,71 INR -2,30 % Intraday Chart für Prism Medico and Pharmacy Limited -5,44 % -28,87 %
13.02. Prism Medico and Pharmacy Limited meldet die Ergebnisse für das dritte Quartal und die neun Monate bis zum 31. Dezember 2023 CI
2023 Prism Medico and Pharmacy Limited meldet die Ergebnisse für das zweite Quartal und die sechs Monate bis zum 30. September 2023 CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Prism Medico and Pharmacy : Submission of confirmation certificate as per Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018 for the quarter ended 31st March, 2024.
Prism Medico and Pharmacy Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Prism Medico and Pharmacy Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Prism Medico and Pharmacy Limited Approves to Regularize the Appointment of Dinesh Kumar as A Director (Non-Executive, Independent Director)
Prism Medico and Pharmacy Limited Reports Earnings Results for the Full Year Ended March 31, 2023
Prism Medico and Pharmacy Limited Announces the Appointment of Mr. Vishwambhar Dayal Gupta as Director
Prism Medico and Pharmacy Limited Appoints Sakshi Laller as A Whole Time Director (Promoter, Executive Director, Women Director)
Prism Medico Appoints CFO
Prism Medico's CFO Resigns
Symbiosis Pharmaceutical Services Limited, Galaxy Vitacare Private Limited, and Ramit Walia completed the acquisition of a 1.07% stake in Prism Medico and Pharmacy Limited for INR 0.71 million
Symbiosis Pharmaceutical Services Limited, Galaxy Vitacare Private Limited and Ramit Walia made an offer to acquire a 26% stake in Prism Medico and Pharmacy Limited from its shareholders for INR 17.34 million
Galaxy Vitacare Private Limited, Symbiosis Pharmaceutical Services Limited and Ramit Walia entered a share purchase agreement to acquire a 23.93% stake in Prism Medico and Pharmacy Limited from Ajooni Biotech Limited, Parmjeet Kaur, Jasjot Singh and Charanjit Singh Bhatia for INR 15.96 million.
Prism Medico and Pharmacy Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Prism Medico and Pharmacy : Disclosure U/R 74(5) Of SEBI (DP) Regulations 2018
Prism Medico and Pharmacy Widens Net Loss in Fiscal Q1; Shares Drop 3%
Prism Medico and Pharmacy Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Prism Medico and Pharmacy : Financial Results Updates
Prism Medico and Pharmacy : Disclosure U/R 32 Of SEBI (LODR) Reg 2015
Prism Medico and Pharmacy : Disc UR 31(4) / 31(5) Of SAST Regulations 2011
Prism Medico and Pharmacy Limited Announces Address Changes
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. PRISMMEDI6 Aktie
  4. Nachrichten Prism Medico and Pharmacy Limited
  5. Andere Sprachen